New insider activity at Lumexa Imaging Holdings, Inc. ( (LMRI) ) has taken place on May 21, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Director Brett Brodnax has increased his stake in Lumexa Imaging Holdings, Inc. by purchasing 35,000 shares of the company’s stock in a recent transaction. The total value of this insider buy comes to $253,750, signaling a notable show of confidence in Lumexa Imaging Holdings, Inc. from a member of its board.
Recent Updates on LMRI stock
Over the last day, Lumexa Imaging saw notable moves as a director purchased 30K shares, which coincided with the stock jumping about 8% in after-hours trading, suggesting renewed investor confidence. At the same time, Barclays cut its price target, citing Lumexa’s slower advanced volume growth and weaker imaging pricing versus peer RadNet, despite Lumexa’s solid Q1 results and reaffirmed guidance.
Spark’s Take on LMRI Stock
According to Spark, TipRanks’ AI Analyst, LMRI is a Neutral.
The score is held back primarily by weak technicals (downtrend below key moving averages) and expensive valuation (P/E ~120x). Financials are improving (better leverage and strong revenue inflection) but remain mixed due to inconsistent profitability and recent free-cash-flow weakness, while the latest earnings call was constructive with reaffirmed guidance and strong advanced-modality growth.
To see Spark’s full report on LMRI stock, click here.
More about Lumexa Imaging Holdings, Inc.
YTD Price Performance: -60.0%
Average Trading Volume: 1,032,297
Technical Sentiment Signal: Strong Sell
Current Market Cap: $711M